IQVIA HoldingsIQV

NYSE · USA · Segment 4 of 8 in the Medicine, pharma & life science value chain: CDMO & pharma manufacturing

Clinical research (CRO) and healthcare data analytics for the pharmaceutical industry.

CDMO & pharma manufacturing: Contract development and manufacturing of medicines — the industrial backbone behind the drugs.

Key metrics

Market cap

$34.6B

Price

$207.84

Today

−0.5%

Return YTD

−7.3%

Return 1Y

+29.0%

P/E

25.0

P/S

2.1

P/B

5.6

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

Clinical research & dataClinical researchHealth dataPharma services

In the value chain

Products & services

Clinical trials (CRO)
Health data & analytics
Commercial pharma services

Competitors

Icon plc
PPD (Thermo Fisher)
Labcorp

Risks

Biotech funding
Data privacy regulation

Same segment: CDMO & pharma manufacturing

West Pharmaceutical ServicesWST Charles River LaboratoriesCRL

See where IQVIA Holdings sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →